Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96

NCT03650257 is registered in ClinicalTrials.gov with Cure&Sure Biotech Co., LTD as lead sponsor.

NCT NCT03650257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03650257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96
Lead sponsor
Cure&Sure Biotech Co., LTD
Phase
Phase 2
Overall status
Unknown status
Start date
August 21, 2019
Completion date
August 20, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma of brain